AlergoImuno centrum s.r.o.
- Address
- Hradska Cesta 2, 060 01 Kežmarok, Slovakia
AlergoImuno centrum s.r.o. - Allergy and Respiratory Research Center
AlergoImuno centrum s.r.o. is a specialized clinical research facility focusing on allergic and immunological disorders, with particular expertise in respiratory conditions and urticaria. The center conducts advanced phase III and phase IIIb clinical trials evaluating novel therapeutic approaches for allergic diseases and asthma management in both adult and pediatric populations.
- Chronic spontaneous and inducible urticaria research, including novel BTK inhibitor therapies and extended treatment protocols
- Asthma trials across severity spectrums, from severe uncontrolled disease to exacerbation prevention studies
- Allergic rhinoconjunctivitis studies, including immunotherapy trials for seasonal allergies induced by birch and grass pollen
- Refractory chronic cough investigations and advanced respiratory symptom management
The center demonstrates comprehensive capabilities in managing complex study designs, including double-blind placebo-controlled trials, active-controlled comparisons, and long-term extension studies. Their research portfolio encompasses cutting-edge treatments such as remibrutinib for urticaria, novel inhaled combination therapies for asthma, and allergen-specific immunotherapy products. With experience in both adult and pediatric populations aged 5 to 17 years, AlergoImuno centrum contributes valuable data to advancing treatment options for patients with allergic and respiratory conditions who remain inadequately controlled on standard therapies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 23 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG3trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in AlergoImuno centrum s.r.o.
lock Showing 1 of 10 trials — the rest is available on a paid plan.
IMP list
lock Showing 1 of 23 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Remibrutinib | 3 | Unknown | 2023-01-24 | 2024-09-30 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.